Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

IMPORTANCE: Whether culture expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy (ICM) remains controversial. OBJECTIVE: To demonstrate the safety of transendocardial stem cell injection with autologous mesenchymal stem cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Heldman, Alan W., DiFede, Darcy L., Fishman, Joel E, Zambrano, Juan P., Trachtenberg, Barry H., Karantalis, Vasileios, Mushtaq, Muzammil, Williams, Adam R., Suncion, Viky Y., McNiece, Ian K., Ghersin, Eduard, Soto, Victor, Lopera, Gustavo, Miki, Roberto, Willens, Howard, Hendel, Robert, Mitrani, Raul, Pattany, Pradip, Feigenbaum, Gary, Oskouei, Behzad, Byrnes, John, Lowery, Maureen H., Sierra, Julio, Pujol, Mariesty V, Delgado, Cindy, Gonzalez, Phillip J., Rodriguez, Jose E., Bagno, Luiza Lima, Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, da Silva, Jose, Anderson, Erica, Schwarz, Richard, Mendizabal, Adam, Hare, Joshua M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111133/
https://ncbi.nlm.nih.gov/pubmed/24247587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.282909
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky